[Elsevier] OA02.03 Overall Survival (OS) with Neoadjuvant Nivolumab Plus Chemotherapy by Surgical Outcomes in the Phase 3 CheckMate 816 Study

thepowerful Post time Yesterday 20:45 | Show all posts |Read mode
This post will be closed automatically in 2026-08-22 20:45
Reward30points

journal:Journal of Thoracic Oncology

Authors:T. Mitsudomi; P.M. Forde; N. Girard; M. Provencio; M.M. Awad; C. Wang; S. Lu; E. Felip; S.R. Broderick; S.J. Swanson; J.R. Brahmer; T.-E. Ciuleanu; F. Tanaka; G.S. Saylors; K.-N. Chen; H. Ito; M. Liberman; C. Martin; E.E. Vokes; L. Wang; N. Hu; S. Lucherini; S.I. Blum; S. Bhatia; J.D. Spicer

Published date:2025-10-

DOI:10.1016/j.jtho.2025.09.033

PDF link:https://www.sciencedirect.com/sc ... 556086425010834/pdf

Article link:https://doi.org/10.1016/j.jtho.2025.09.033

Article Source:Elsevier BV


Remark:
Reply

Use magic Donate Report

All Reply0 Show all posts
Mrjian Post time Yesterday 22:30 | Show all posts
Please approve

【Rejected: Invalid Reply】Dense_Nested_Attention_Network_for_Infrared_Small_Target_Detection.pdf

4.81 MB, Downloads: 2

Document validity period: 10 days
Reply

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    11730


Return to the list